The Staff Selection Commission (SSC) is expected to announce the CGL Tier I Result 2025 within the next few days. Lakhs of ...

Bloomberg’s August Global Regulatory Brief reviews recent global regulatory developments, focusing on the UK, EU, Saudi ...

Basel, October 29, 2025 – Novartis today presented new ianalumab data in Sjögren’s disease, the second most prevalent rheumatic autoimmune disease 2, at a late-breaker presentation during the American ...

The PCI SSC guidelines emphasize the importance of transparency and addressing the challenges associated with AI use.

Objective Interstitial lung disease (ILD) represents the most common and severe organ manifestation observed in patients ...

Abbott Laboratories has won a legal case claiming its Similac infant formula caused the death of a baby from necrotizing ...

Cabaletta Bio ( ($CABA) ) has issued an update. On October 27, 2025, Cabaletta Bio announced positive clinical data and development updates from ...

CD19 chimeric antigen receptor T-cell therapy improved lung function and skin thickness in patients with severe refractory ...

As of a September 25, 2025 data cut-off-date, 10 patients with treatment-refractory, moderate-to-severe Systemic Lupus Erythematosus (SLE) were ...

Squibb announced updated data and first disclosure of results in chronic, refractory autoimmune diseases from the Phase 1 ...

BMS Presents Encouraging Data from Phase 1 Breakfree-1 Study of CD19 NEX-T™ CAR T Cell Therapy in Three Chronic Autoimmune Diseases at ACR.